|  | CRC death/ no. at risk | All CRC (n = 4365) | ||
---|---|---|---|---|---|
HR | 95Â % CI | p-value | |||
Site | Colon | 923/2847 | 1.00 | - | - |
Rectum | 487/1518 | 0.85 | 0.74-0.98 | 0.022 | |
Stage dukes | A | 55/933 | 1.00 | - | - |
B | 250/1438 | 2.97 | 2.21-3.99 | 0.000 | |
C | 520/1345 | 7.74 | 5.75-10.4 | 0.000 | |
D | 585/649 | 34.1 | 25.0-46.5 | 0.000 | |
Grade | Low | 10/114 | 1.00 | - | - |
Intermediate | 826/3137 | 1.22 | 0.72-2.07 | 0.453 | |
High | 405/825 | 2.25 | 1.32-3.84 | 0.003 | |
Unknown | 159/289 | 2.09 | 1.20-3.64 | 0.010 | |
Age group | 50-59 | 298/901 | 1.00 | - | - |
60-69 | 467/1552 | 1.04 | 0.89-1.21 | 0.600 | |
70-79 | 645/1942 | 1.12 | 0.96-1.29 | 0.146 | |
Sex | Female | 585/1867 | 1.00 | - | - |
Male | 825/2498 | 1.07 | 0.95-1.20 | 0.243 | |
Private Insurance | No | 686/1985 | 1.00 | - | - |
Yes | 724/2380 | 0.95 | 0.84-1.06 | 0.335 | |
Comorbidity | None | 941/3068 | 1.00 | - | - |
One (not severe) | 248/779 | 0.90 | 0.78-1.05 | 0.194 | |
Multiple / severe | 221/518 | 1.21 | 1.02-1.44 | 0.033 | |
SES quintile | Low | 382/1072 | 1.00 | - | - |
Low-mid | 280/878 | 0.94 | 0.80-1.11 | 0.443 | |
Middle | 246/791 | 0.93 | 0.78-1.10 | 0.379 | |
Mid-high | 276/843 | 1.06 | 0.90-1.25 | 0.508 | |
High | 226/781 | 0.75 | 0.62-0.91 | 0.004 | |
Residence | Urban | 1007/3102 | 1.00 | - | - |
Outer urban | 122/429 | 0.95 | 0.79-1.16 | 0.638 | |
Rural | 47/188 | 0.98 | 0.82-1.17 | 0.830 | |
Remote | 93/242 | 1.12 | 0.90-1.39 | 0.324 | |
Surgerya | No | 230/295 | 1.00 | - | - |
Yes | 1180/4070 | 0.51 | 0.42-0.62 | 0.000 | |
Radiotherapya | No | 1141/3757 | 1.00 | - | - |
Yes | 36/269 | 1.41 | 1.18-1.68 | 0.000 | |
Chemotherapya | No | 632/2745 | 1.00 | - | - |
Yes | 778/1620 | 0.87 | 0.76-1.00 | 0.047 | |
Diagnosis year | (continuous) | 1410/4365 | 0.95 | 0.92-0.98 | 0.002 |